What stands between people and cancer screening
Core finding
The cancer questions show a clear gap between interest in screening and concern about the cost of care.
Adults broadly value noninvasive multi-cancer early detection tests, but the same cluster shows strong concern about the financial impact if cancer care is needed.
Screening interest is high
A 74.9% share said it is very important for the healthcare system to offer noninvasive multi-cancer early detection tests.
Another 67.0% said they would be somewhat or very likely to complete one of these tests.
Stacked breakdown
74.9% call these tests very important for the healthcare system.
n = 1,000 · May 1–4, 2026 · MoE ±3.3%
Trust and follow-through shape the story
A 61.4% share agreed that they would trust the results of these tests as much as traditional cancer screening at a doctor's office.
An 81.3% share said they would be somewhat or very likely to take action based on the results.
Stacked breakdown
81.3% say they would likely act on test results.
n = 1,000 · May 1–4, 2026 · MoE ±3.3%
Cost concern remains high
A 72.7% share said they would be very or extremely concerned about the household financial impact if they or someone in their household needed cancer care.
Stacked breakdown
72.7% are very or extremely concerned about cancer-care costs.
n = 1,000 · May 1–4, 2026 · MoE ±3.3%
Methodology
Full methodology →| Mode | Verasight panel recruited via random address-based sampling, random person-to-person text messaging, and dynamic online targeting |
|---|---|
| Population | US adults age 18+ |
| Field dates | May 1–4, 2026 |
| Base (unweighted) | 1,000 |
| Margin of error | ±3.3% |
| Module | 2 |
| Sponsor | Verasight |
| Weight variable | weight |
| Weighting targets | age, race/ethnicity, sex, income, education, region, metropolitan status |
Sources
- reports.verasight.io/r/sbm-2026
How important is it for the healthcare system to offer noninvasive multi-cancer early detection tests (e.g., Galleri, Cologuard)?
- reports.verasight.io/r/sbm-2026
How likely are you to complete a noninvasive multi-cancer early detection test (e.g., Galleri, Cologuard)?
- reports.verasight.io/r/sbm-2026
To what extent do you agree or disagree with the following statement: "I would trust the results of noninvasive multi-cancer early detection tests (e.g., Galleri, Cologuard) as much as a traditional cancer screening at my doctor's office."
- reports.verasight.io/r/sbm-2026
How likely are you to take action based on the results of a noninvasive multi-cancer early detection tests (e.g., Galleri, Cologuard)?
- reports.verasight.io/r/sbm-2026
If you or someone in your household needed cancer care, how concerned would you be about the financial impact on your household?
Cite this topic
SBM Omnibus Survey #2026-049, fielded May 1-4, 2026, N=1,000 US adults age 18+, +/- 3.3%.